Prothena (PRTA) Earnings Date & Reports

Prothena Corp PLC is a clinical biotechnology company that focuses on protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating neurodegenerative and rare and peripheral amyloid diseases... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

PRTA is expected to report earnings to fall 13.28% to -97 cents per share on August 07

Q2'25

Est.

$-0.97

Q1'25

Beat

by $0.11

Q4'24

Missed

by $0.08

Q3'24

Beat

by $0.08

Q2'24

Beat

by $2.28

The last earnings report on May 08 showed earnings per share of -112 cents, beating the estimate of -123 cents. With 1.66M shares outstanding, the current market capitalization sits at 399.93M.

View a ticker or compare two or three

Compare

PRTA